- Original Article
- Hematology
- Treatment and clinical outcomes of pediatric autoimmune hemolytic anemia: real-world single-center data from Korea
-
Young Dai Kwon, Eun Sun Jung, Yeon Jung Lim
-
Clin Exp Pediatr. 2025;68(7):522-529. Published online April 16, 2025
-
|
Question: Can pediatric autoimmune hemolytic anemia (AIHA) be effectively managed using first-line steroids?
Finding: In this single-center study, pediatric patients with AIHA achieved normal hemoglobin levels within 16.5 days (range, 9.0–22.0 days) of first-line steroid treatment and maintained effective responses for 2 months.
Meaning: These outcomes highlight the efficacy of steroid treatment in pediatric versus adult AIHA and underscore the need for multicenter trials to establish standardized treatment guidelines. |
-
-
|